A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

Comparative Hepatology

Volumn 1, Issue , 2002, Pages

  Halfon, Philippe ^a   Imbert Bismut, Françoise ^b   Messous, Djamila ^b   Antoniotti, Gilles ^c   Benchetrit, Didier ^d   Cart Lamy, Philippe ^e   Delaporte, Gilles ^f   Dotheau, Danièle ^g   Klump, Théo ^h   Sala, Michel ⁱ   Thibaud, Didier ^j   Trepo, Elisabeth ^k   Thabut, Dominique ^b   Myers, Robert P ^b   Poynard, Thierry ^b  

^a Laboratoire Alphabio   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Laboratoire Biomedica   (France)

^d Laboratoire Barla   (France)

^e Laboratoire Clinilab   (France)

^f Laboratoire Delaporte   (France)

^g LMM Laboratoire Marcel Merieux   (France)

^h Laboratoire Klump   (France)

ⁱ Laboratoire Claude Levy   (France)

^j Laboratoire Sery   (France)

^k Centre de Biologie Est   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; BIOCHEMICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; PYRIDOXAL 5 PHOSPHATE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ASSAY; FEMALE; HEPATITIS C; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; LIVER FIBROSIS; MALE; METHODOLOGY; MULTICENTER STUDY; PREDICTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REFERENCE VALUE; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

EID: 0042553522     PISSN: 14765926     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-5926-1-3     Document Type: Article

References (15)

1. EASL International Consensus Conference on hepatitis C. Paris 26-27 February 1999 Consensus statement. J Hepatol 1999, 31:3-8
2. Poynard T, Ratziu V and Bedossa P Appropriateness of liver biopsy. Can J Gastroenterol 2000, 14:543-548
3. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D and Pudifin DJ Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986, 1 (8480):523-525
4. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T and for the MULTIVIRC group Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075
5. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, Messous D and Degos F Biochemical markers of liver fibrosis in patients infected by Hepatitis C Virus: Longitudinal validation in a randomized trial. J Viral Hepatitis 2002, 9:128-133
6. Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C and Poynard T Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients. AIDS
7. Adams L, Rossi E, DeBoer B, Speers D, Macquillan G, Garas G and Jeffrey G Use of Fibrotest to predict liver fibrosis in hepatitis C: a replacement for liver biopsy? [abstract] Gastroenterology 2002, 122:1615A
8. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, Sansonetti N and Opolon P Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998, 27:1213-1219
9. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanusco F, Mozzi F, Milani S, Conte D, Colombo M and Sirchia G Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002, 137:1-9
10. Myara A, Ferard G, Guechot J, Imbert-Bismut F, Lasnier E, Piton A, Voitot H and Dhumeaux D Calibration to achieve standardization in enzymology, example of ALT [abstract]. 14th European Congress of Clinical Chemistry and Laboratory Medicine, Prague May 26-31 2001
11. Persijn JP and van der Slik W A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem 1976, 14:421-427
12. Hintze JL NCSS 2001 User Guide. Number Cruncher Statistical Systems. Kaysville, Utah 2001,
13. Bablok W, Passing H, Bender R and Schneider B A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem 1988, 26:783-790
14. Ferard G, Edwards J, Kanno T, Lessinger JM, Moss DW, Schiele F, Tietz NW and Vassauly A Interassay calibration as a major contribution to the comparability of results in clinical enzymology. Clin Biochem 1998, 31:489-494
15. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M and Albrecht JK Peg-Interferon alfa-2b in combination with ribavirin compared to interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. Lancet 2001, 358:958-965